Last quarter (Q2 2025), Britannia Life Sciences Inc's total revenue was $1.96M, a decrease of -5.71% from the same quarter last year. In Q2, Britannia Life Sciences Inc's net income was $-1.19M. See Britannia Life Sciences Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 24	Mar 23	Mar 22	Mar 21
Total Revenue	$ -305.71K	$ ―	$ 6.40M	$ 7.30M	$ 1.42M
Cost of Revenue	$ 2.85M	$ 2.72M	$ 1.77M	$ 2.04M	$ 253.03K
Gross Profit	$ -3.16M	$ -2.72M	$ 4.64M	$ 5.26M	$ 1.17M
Operating Expense	$ 8.59M	$ 8.84M	$ 3.63M	$ 13.62M	$ 889.02K
Operating Income	$ -11.75M	$ -11.56M	$ 1.01M	$ -8.36M	$ 282.56K
Net Non Operating Interest Income Expense	$ -570.26K	$ ―	$ -816.35K	$ -1.24M	$ -358.30K
Other Income Expense	$ -6.69M	$ -8.36M	$ -5.74M	$ -2.74M	$ 476.37K
Pretax Income	$ -7.21M	$ -4.47M	$ 5.86M	$ -7.47M	$ 400.64K
Tax Provision	$ -216.79K	$ -67.36K	$ 19.86K	$ -711.59K	$ 257.66K
Earnings From Equity Interest Net Of Tax	$ -1.72M	$ -959.16K	$ -18.33K	$ -55.00	$ ―
Net Income Common Stockholders	$ -7.31M	$ -4.77M	$ 5.08M	$ -8.23M	$ -157.16K
Basic EPS	$ -0.05	$ -0.03	$ 0.03	$ -0.14	$ >-0.01
Diluted EPS	$ -0.05	$ -0.03	$ 0.03	$ -0.14	$ >-0.01
Basic Average Shares	$ 649.02M	$ 162.25M	$ 162.14M	$ 109.50M	$ 77.63M
Diluted Average Shares	$ 649.02M	$ 162.25M	$ 162.14M	$ 109.50M	$ 77.63M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 11.44M	$ 11.56M	$ 5.40M	$ 15.66M	$ 1.14M
Net Income From Continuing And Discontinued Operation	$ -7.31M	$ -4.77M	$ 5.08M	$ -8.23M	$ -157.16K
Normalized Income	$ -8.17M	$ -4.96M	$ 4.32M	$ -8.18M	$ -507.30K
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ 358.30K
EBIT	$ -6.79M	$ -4.47M	$ 6.67M	$ -6.23M	$ 758.94K
EBITDA	$ -6.43M	$ -4.14M	$ 6.90M	$ -6.04M	$ 794.39K

Currency in USD

Britannia Life Sciences Inc Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing